The Food and Drug Administration (FDA) is establishing a public docket to collect comments related to the post-marketing pediatric-focused safety reviews of products posted between October 23, 2017, and March 16, 2018, on FDA's website but not presented at the March 23, 2018, Pediatric Advisory Committee (PAC) meeting. These reviews are intended to be available for review and comment by members of the PAC, interested parties (such as academic researchers, regulated industries, consortia, and patient groups), and the general public.
Document
Post-Marketing Pediatric-Focused Product Safety Reviews; Establishment of a Public Docket; Request for Comments
The Food and Drug Administration (FDA) is establishing a public docket to collect comments related to the post-marketing pediatric-focused safety reviews of products posted betw...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 9324
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Post-Marketing Pediatric-Focused Product Safety Reviews; Establishment of a Public Docket; Request for Comments,” thefederalregister.org (March 5, 2018), https://thefederalregister.org/documents/2018-04400/post-marketing-pediatric-focused-product-safety-reviews-establishment-of-a-public-docket-request-for-comments.